Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verastem, Inc. | Director | Common Stock | 8.33K | $26.3K | $3.16 | Jun 18, 2024 | Direct |
GERON CORP | EVP, Corp Strategy & CCO | Common Stock | 0 | $0 | $4.65 | Jun 10, 2024 | Direct |
GERON CORP | EVP, Corp Strategy & CCO | Stock Option (right to buy) | 328K | Jun 10, 2024 | Direct | ||
Nurix Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 50K | Oct 15, 2024 | Direct | ||
Verastem, Inc. | Director | Stock Option (right to buy) | 12.5K | Jun 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NRIX | Nurix Therapeutics, Inc. | Oct 15, 2024 | 1 | $0 | 4 | Oct 16, 2024 | Director |
NRIX | Nurix Therapeutics, Inc. | Oct 15, 2024 | 0 | $0 | 3 | Oct 16, 2024 | Director |
VSTM | Verastem, Inc. | Jun 18, 2024 | 2 | $0 | 4 | Jun 20, 2024 | Director |
GERN | GERON CORP | Jun 10, 2024 | 3 | -$1.51M | 4 | Jun 12, 2024 | EVP, Corp Strategy & CCO |
GERN | GERON CORP | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | EVP, Corp Strategy & CCO |
GERN | GERON CORP | Feb 14, 2024 | 1 | $0 | 4 | Feb 16, 2024 | EVP, CORP STRATEGY & CCO |
GERN | GERON CORP | Jun 30, 2023 | 1 | $15.4K | 4 | Jun 30, 2023 | EVP, Corp Strategy & CCO |
VSTM | Verastem, Inc. | May 15, 2023 | 1 | $0 | 4 | May 16, 2023 | Director |
GERN | GERON CORP | Feb 22, 2023 | 1 | $0 | 4 | Feb 24, 2023 | EVP, Corp Strategy & CCO |
GERN | GERON CORP | Dec 30, 2022 | 1 | $6.68K | 4 | Jan 3, 2023 | EVP, Corp Strategy & CCO |
VSTM | Verastem, Inc. | Oct 20, 2022 | 1 | $0 | 4 | Oct 24, 2022 | Director |
VSTM | Verastem, Inc. | Oct 20, 2022 | 0 | $0 | 3 | Oct 24, 2022 | Director |
GERN | GERON CORP | Jun 30, 2022 | 1 | $14.5K | 4 | Jul 1, 2022 | EVP, Corp Strategy & CCO |
GERN | GERON CORP | Feb 16, 2022 | 1 | $0 | 4 | Feb 18, 2022 | EVP, Corp Strategy & CCO |